These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7647339)

  • 1. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.
    Dran G; Luthy IA; Molinolo AA; Montecchia F; Charreau EH; Pasqualini CD; Lanari C
    Breast Cancer Res Treat; 1995 Aug; 35(2):173-86. PubMed ID: 7647339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation.
    Lamb C; Simian M; Molinolo A; Pazos P; Lanari C
    J Steroid Biochem Mol Biol; 1999; 70(4-6):133-42. PubMed ID: 10622401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
    Montecchia MF; Lamb C; Molinolo AA; Luthy IA; Pazos P; Charreau E; Vanzulli S; Lanari C
    J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):11-21. PubMed ID: 10215033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
    Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas.
    Elizalde PV; Lanari C; Molinolo AA; Guerra FK; Balañá ME; Simian M; Iribarren AM; Charreau EH
    J Steroid Biochem Mol Biol; 1998 Nov; 67(4):305-17. PubMed ID: 9883987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen inhibition of MPA-induced mouse mammary tumor transplants.
    Kordon E; Lanari C; Molinolo AA; Elizalde PV; Charreau EH; Dosne Pasqualini C
    Int J Cancer; 1991 Dec; 49(6):900-5. PubMed ID: 1835715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of estrogen-resistance in murine mammary adenocarcinomas.
    Montecchia MF; Molinolo A; Lanari C
    Breast Cancer Res Treat; 1999 Mar; 54(2):93-9. PubMed ID: 10424399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines.
    Lanari C; Kordon E; Molinolo A; Pasqualini CD; Charreau EH
    Int J Cancer; 1989 May; 43(5):845-50. PubMed ID: 2523869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
    Couture P; Thériault C; Simard J; Labrie F
    Endocrinology; 1993 Jan; 132(1):179-85. PubMed ID: 8380373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate.
    Kordon E; Lanari C; Meiss R; Elizalde P; Charreau E; Dosne Pasqualini C
    Breast Cancer Res Treat; 1990 Nov; 17(1):33-43. PubMed ID: 2151368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of estrogen, progesterone, androgen and glucocorticoid on death of neonatal mouse uterine epithelial cells induced to proliferate by estrogen.
    Jo T; Terada N; Saji F; Tanizawa O
    J Steroid Biochem Mol Biol; 1993 Jul; 46(1):25-32. PubMed ID: 8338788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of EGF in medroxyprogesterone acetate (MPA)-induced mammary gland hyperplasia and its role in MPA-induced mammary tumors in BALB/c mice.
    Molinolo A; Simian M; Vanzulli S; Pazos P; Lamb C; Montecchia F; Lanari C
    Cancer Lett; 1998 Apr; 126(1):49-57. PubMed ID: 9563648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor.
    Efeyan A; Fabris V; Merani S; Lanari C; Molinolo AA
    Breast Cancer Res Treat; 2004 Feb; 83(3):233-44. PubMed ID: 14758093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of steroid hormones and antihormones in cultured cells.
    Jung-Testas I; Baulieu EE
    Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.
    Kordon EC; Molinolo AA; Pasqualini CD; Charreau EH; Pazos P; Dran G; Lanari C
    Breast Cancer Res Treat; 1993 Oct; 28(1):29-39. PubMed ID: 8123867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor.
    Hackenberg R; Hawighorst T; Filmer A; Nia AH; Schulz KD
    Breast Cancer Res Treat; 1993; 25(3):217-24. PubMed ID: 8369523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
    Poulin R; Baker D; Poirier D; Labrie F
    Breast Cancer Res Treat; 1989 Mar; 13(2):161-72. PubMed ID: 2525057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors].
    Lanari C; Montecchia MF; Pazos P; Simian M; Vanzulli S; Lamb C; Molinolo AA
    Medicina (B Aires); 1997; 57 Suppl 2():55-69. PubMed ID: 9567344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat.
    Martel C; Sourla A; Pelletier G; Labrie C; Fournier M; Picard S; Li S; Stojanovic M; Labrie F
    J Endocrinol; 1998 Jun; 157(3):433-42. PubMed ID: 9691976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma.
    Lamb CA; Helguero LA; Fabris V; Lucas C; Molinolo AA; Lanari C
    Breast Cancer Res Treat; 2003 May; 79(1):25-35. PubMed ID: 12779079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.